Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Marybeth McCauley
FHI 360
Washington, DC
United States
Contact
FHI 360
Email
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
56
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Tail-Phase Safety, Tolerability, and Pharmacokinetics of Long-Acting Injectable Cabotegravir in HIV-Uninfected Adults: HPTN 077
Number of pages: 169
Posted: 05 Sep 2019
Raphael Landovitz
,
Sue Li
,
Joseph J. Eron Jr.
,
Beatriz Grinsztejn
,
Halima Dawood
,
Albert Y. Liu
,
Manya Magnus
,
Mina C. Hosseinipour
,
Ravindre Panchia
,
Leslie Cottle
,
Gordon Chau
,
Paul Richardson
,
Mark A. Marzinke
,
Susan Eshleman
,
Ryan Kofron
,
Adeola Adeyeye
,
David Burns
,
Alex R. Rinehart
,
David Margolis
,
Myron S. Cohen
, Marybeth McCauley and
Craig W. Hendrix
University of California, Los Angeles (UCLA) - UCLA Center for Clinical AIDS Research and Education, Fred Hutchinson Cancer Research Center - Statistical Center for HIV/AIDS Research and Prevention, University of North Carolina (UNC) at Chapel Hill, - Evandro Chagas National Institute of Infectious Diseases (INI), University of KwaZulu-Natal - Centre for the AIDS Programme of Research in South Africa (CAPRISA), San Francisco Department of Health - Bridge HIV, George Washington University - Department of Epidemiology, University of North Carolina (UNC) at Chapel Hill - UNC-Project Malawi, Chris Hani Baragwanath Academic Hospital - Perinatal HIV Research Unit, Fred Hutchinson Cancer Research Center - Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center - Statistical Center for HIV/AIDS Research and Prevention, Johns Hopkins University - School of Medicine, Johns Hopkins University - School of Medicine, Johns Hopkins University - Department of Pathology, University of California, Los Angeles (UCLA) - UCLA Center for Clinical AIDS Research and Education, Government of the United States of America - National Institute of Allergy and Infectious Diseases (NIAID), Government of the United States of America - National Institutes of Health (NIH), ViiV Healthcare Ltd., ViiV Healthcare Ltd., University of North Carolina (UNC) at Chapel Hill, FHI 360 and Johns Hopkins University - School of Medicine
Downloads
56
(1,000,027)
View PDF
Download
Abstract:
HIV Prevention, Cabotegravir, PrEP, Pre-Exposure Prophylaxis
Feedback